RSV

2024 - 5 - 31

RSV Surge Post-COVID: Study Reveals Surprising Facts

COVID-19 pandemic - FDA approval - Moderna - RSV - vaccine development

Discover how RSV cases escalated after the pandemic and new tools aiding drug development for respiratory infections.

RSV (Respiratory syncytial virus) has been making headlines again, with a recent study delving into the surge in RSV cases following the COVID-19 pandemic. Known for causing mild, cold-like symptoms, RSV has raised concerns due to the unexpected increase in infections. The Centers for Disease Control and Prevention have been closely monitoring the situation as the virus continues to impact individuals worldwide.

The study not only focuses on the rise in RSV cases but also sheds light on new tools that are revolutionizing the development of drugs for respiratory infections. These innovative tools play a crucial role in understanding and combating RSV, a common respiratory infection that affects the lower lungs. With symptoms often resembling a cold, RSV can lead to severe complications if not managed effectively.

Interestingly, individuals infected with RSV may experience similar mild symptoms as those with a common cold. The overlap in symptoms adds complexity to diagnosing and treating RSV infections effectively. As researchers continue to study the virus and its implications, the need for advanced tools and therapies becomes more apparent.

In conclusion, the study highlights the urgency of addressing RSV outbreaks, especially in a post-pandemic world. Understanding the dynamics of respiratory infections like RSV is vital for developing targeted treatments and preventive measures to safeguard public health.

Post cover
Image courtesy of "Medical Xpress"

Study examines surge in RSV cases after the COVID-19 pandemic (Medical Xpress)

Respiratory syncytial virus, or RSV, is a common virus that usually causes mild, cold-like symptoms, according to the Centers for Disease Control and Prevention ...

Post cover
Image courtesy of "Pharmacy Times"

Study: New Tools Aid Development of Drugs for Respiratory ... (Pharmacy Times)

RSV is a common respiratory infection that impacts the lower lungs and can cause mild symptoms that are comparable to those of a cold. Individuals infected with ...

Ongoing Phase 2/3 Trial Evaluates Efficacy of mRNA-1345 Vaccine ... (Pharmacy Times)

In a trial conducted by ModernaTX, Inc, investigators are assessing the safety and efficacy of the mRNA-1345 vaccine to target respiratory syncytial virus (RSV) ...

Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) (Moderna Investor Relations)

mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, ...

Moderna wins FDA approval for RSV vaccine (BioPharma Dive)

Dubbed mResvia, the shot is cleared for use in older adults to prevent disease caused by RSV, a respiratory virus that circulates widely in the fall and ...

Post cover
Image courtesy of "STAT"

FDA approves Moderna's RSV vaccine, its second licensed product (STAT)

The Food and Drug Administration on Friday approved Moderna's vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the ...

Post cover
Image courtesy of "Reuters"

US FDA approves Moderna's RSV vaccine, its second marketed ... (Reuters)

The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at ...

Post cover
Image courtesy of "The Hill"

FDA approves Moderna's mRNA RSV vaccine (The Hill)

The Food and Drug Administration (FDA) has approved Moderna's RSV mRNA vaccine for adults over the age of 60. The approval makes RSV the second disease for ...

Post cover
Image courtesy of "CNBC"

FDA approves Moderna's RSV vaccine for seniors, the company's ... (CNBC)

The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.

FDA Approves Moderna's RSV Vaccine for Seniors (Contagionlive.com)

The company's mRNA 1345 vaccine was given the nod by the federal agency and is indicated for seniors for the prevention of RSV-associated lower respiratory ...

FDA Approves mRNA-1345 for Protection of Lower Respiratory Tract ... (Pharmacy Times)

This is Moderna's second mRNA vaccine approval and the first mRNA vaccine approved for an indication other than COVID-19.

Moderna Receives FDA Nod For Single-Dose RSV mRNA Vaccine (AJMC.com Managed Markets Network)

The FDA approved mRNA-1345, a Moderna vaccine for the treatment of respiratory syncytial virus (RSV). This single-dose vaccine offers protection against ...

Post cover
Image courtesy of "Financial Times"

Moderna wins second approval with vaccine targeting RSV infection (Financial Times)

US decision hands biotech group its first regulatory blessing since its blockbuster Covid-19 jab.

Post cover
Image courtesy of "FiercePharma"

Moderna secures FDA approval for RSV vaccine mRESVIA (FiercePharma)

With the FDA nod, Moderna's RSV vaccine becomes the company's second product to secure the FDA's backing.

Post cover
Image courtesy of "CNN"

FDA approves Moderna's mRNA RSV vaccine for older adults (CNN)

The US Food and Drug Administration has approved another vaccine that can help protect older people from respiratory syncytial virus, known as RSV.

FDA approves Moderna's mRNA RSV vaccine for older adults - KTVZ (KTVZ)

The shot, made by Moderna and sold under the name of mResvia, could be another tool in the country's RSV arsenal in the fall. Moderna's shot is the third RSV ...

Explore the last week